1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD
(
- Contribution to journal › Article
- 2022
-
Mark
Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson's disease
(
- Contribution to journal › Article
- 2021
-
Mark
A quantitative model of cellular decision making in direct neuronal reprogramming
(
- Contribution to journal › Article
- 2020
-
Mark
GDNF and Parkinson's Disease : Where Next? A Summary from a Recent Workshop
(
- Contribution to journal › Article
- 2018
-
Mark
New approaches for brain repair-from rescue to reprogramming
(
- Contribution to journal › Scientific review
-
Mark
11C-PE2I and 18F-Dopa PET for assessing progression rate in Parkinson's : A longitudinal study
(
- Contribution to journal › Article
- 2017
-
Mark
Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease : A cross-sectional study of iron-related magnetic resonance imaging susceptibility
(
- Contribution to journal › Article
- 2016
-
Mark
Statins are underused in recent-onset Parkinson's disease with increased vascular risk : findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
(
- Contribution to journal › Article
-
Mark
Aberrant nigral diffusion in Parkinson's disease : A longitudinal diffusion tensor imaging study
(
- Contribution to journal › Article
-
Mark
Increased serotonin-to-dopamine transporter ratios in Parkinson disease dyskinesias: a longitudinal study
(
- Contribution to conference › Abstract